Global mRNA Vaccines and mRNA Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global mRNA Vaccines and mRNA Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the mRNA Vaccines and mRNA Drugs industry chain, the market status of Infectious Disease (Vaccine, API), Cancer (Vaccine, API), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of mRNA Vaccines and mRNA Drugs.
Regionally, the report analyzes the mRNA Vaccines and mRNA Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global mRNA Vaccines and mRNA Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the mRNA Vaccines and mRNA Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the mRNA Vaccines and mRNA Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Vaccine, API).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the mRNA Vaccines and mRNA Drugs market.
Regional Analysis: The report involves examining the mRNA Vaccines and mRNA Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the mRNA Vaccines and mRNA Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to mRNA Vaccines and mRNA Drugs:
Company Analysis: Report covers individual mRNA Vaccines and mRNA Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards mRNA Vaccines and mRNA Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Infectious Disease, Cancer).
Technology Analysis: Report covers specific technologies relevant to mRNA Vaccines and mRNA Drugs. It assesses the current state, advancements, and potential future developments in mRNA Vaccines and mRNA Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the mRNA Vaccines and mRNA Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
mRNA Vaccines and mRNA Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe mRNA Vaccines and mRNA Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of mRNA Vaccines and mRNA Drugs, with price, sales, revenue and global market share of mRNA Vaccines and mRNA Drugs from 2018 to 2023.
Chapter 3, the mRNA Vaccines and mRNA Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the mRNA Vaccines and mRNA Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and mRNA Vaccines and mRNA Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of mRNA Vaccines and mRNA Drugs.
Chapter 14 and 15, to describe mRNA Vaccines and mRNA Drugs sales channel, distributors, customers, research findings and conclusion.
The Global Info Research report includes an overview of the development of the mRNA Vaccines and mRNA Drugs industry chain, the market status of Infectious Disease (Vaccine, API), Cancer (Vaccine, API), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of mRNA Vaccines and mRNA Drugs.
Regionally, the report analyzes the mRNA Vaccines and mRNA Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global mRNA Vaccines and mRNA Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the mRNA Vaccines and mRNA Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the mRNA Vaccines and mRNA Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Vaccine, API).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the mRNA Vaccines and mRNA Drugs market.
Regional Analysis: The report involves examining the mRNA Vaccines and mRNA Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the mRNA Vaccines and mRNA Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to mRNA Vaccines and mRNA Drugs:
Company Analysis: Report covers individual mRNA Vaccines and mRNA Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards mRNA Vaccines and mRNA Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Infectious Disease, Cancer).
Technology Analysis: Report covers specific technologies relevant to mRNA Vaccines and mRNA Drugs. It assesses the current state, advancements, and potential future developments in mRNA Vaccines and mRNA Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the mRNA Vaccines and mRNA Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
mRNA Vaccines and mRNA Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Vaccine
- API
- Infectious Disease
- Cancer
- Thermo Fisher
- Merck
- Qiagen N.V.
- CureVac
- In-Cell-Art
- eTheRNA
- Takara Bio Inc.
- Sangamo Therapeutics
- Roche CustomBiotech
- BioNTech
- Tiba Biotechnology
- TriLink Bio Technologies
- Argos Therapeutics
- Moderna Therapeutics
- NEB
- Ethris
- Aldevron
- Promega
- Translate Bio
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe mRNA Vaccines and mRNA Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of mRNA Vaccines and mRNA Drugs, with price, sales, revenue and global market share of mRNA Vaccines and mRNA Drugs from 2018 to 2023.
Chapter 3, the mRNA Vaccines and mRNA Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the mRNA Vaccines and mRNA Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and mRNA Vaccines and mRNA Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of mRNA Vaccines and mRNA Drugs.
Chapter 14 and 15, to describe mRNA Vaccines and mRNA Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of mRNA Vaccines and mRNA Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global mRNA Vaccines and mRNA Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Vaccine
1.3.3 API
1.4 Market Analysis by Application
1.4.1 Overview: Global mRNA Vaccines and mRNA Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Infectious Disease
1.4.3 Cancer
1.5 Global mRNA Vaccines and mRNA Drugs Market Size & Forecast
1.5.1 Global mRNA Vaccines and mRNA Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global mRNA Vaccines and mRNA Drugs Sales Quantity (2018-2029)
1.5.3 Global mRNA Vaccines and mRNA Drugs Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business
2.1.3 Thermo Fisher mRNA Vaccines and mRNA Drugs Product and Services
2.1.4 Thermo Fisher mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Thermo Fisher Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck mRNA Vaccines and mRNA Drugs Product and Services
2.2.4 Merck mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck Recent Developments/Updates
2.3 Qiagen N.V.
2.3.1 Qiagen N.V. Details
2.3.2 Qiagen N.V. Major Business
2.3.3 Qiagen N.V. mRNA Vaccines and mRNA Drugs Product and Services
2.3.4 Qiagen N.V. mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Qiagen N.V. Recent Developments/Updates
2.4 CureVac
2.4.1 CureVac Details
2.4.2 CureVac Major Business
2.4.3 CureVac mRNA Vaccines and mRNA Drugs Product and Services
2.4.4 CureVac mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 CureVac Recent Developments/Updates
2.5 In-Cell-Art
2.5.1 In-Cell-Art Details
2.5.2 In-Cell-Art Major Business
2.5.3 In-Cell-Art mRNA Vaccines and mRNA Drugs Product and Services
2.5.4 In-Cell-Art mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 In-Cell-Art Recent Developments/Updates
2.6 eTheRNA
2.6.1 eTheRNA Details
2.6.2 eTheRNA Major Business
2.6.3 eTheRNA mRNA Vaccines and mRNA Drugs Product and Services
2.6.4 eTheRNA mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 eTheRNA Recent Developments/Updates
2.7 Takara Bio Inc.
2.7.1 Takara Bio Inc. Details
2.7.2 Takara Bio Inc. Major Business
2.7.3 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Product and Services
2.7.4 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Takara Bio Inc. Recent Developments/Updates
2.8 Sangamo Therapeutics
2.8.1 Sangamo Therapeutics Details
2.8.2 Sangamo Therapeutics Major Business
2.8.3 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
2.8.4 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sangamo Therapeutics Recent Developments/Updates
2.9 Roche CustomBiotech
2.9.1 Roche CustomBiotech Details
2.9.2 Roche CustomBiotech Major Business
2.9.3 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Product and Services
2.9.4 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Roche CustomBiotech Recent Developments/Updates
2.10 BioNTech
2.10.1 BioNTech Details
2.10.2 BioNTech Major Business
2.10.3 BioNTech mRNA Vaccines and mRNA Drugs Product and Services
2.10.4 BioNTech mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 BioNTech Recent Developments/Updates
2.11 Tiba Biotechnology
2.11.1 Tiba Biotechnology Details
2.11.2 Tiba Biotechnology Major Business
2.11.3 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Product and Services
2.11.4 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Tiba Biotechnology Recent Developments/Updates
2.12 TriLink Bio Technologies
2.12.1 TriLink Bio Technologies Details
2.12.2 TriLink Bio Technologies Major Business
2.12.3 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Product and Services
2.12.4 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 TriLink Bio Technologies Recent Developments/Updates
2.13 Argos Therapeutics
2.13.1 Argos Therapeutics Details
2.13.2 Argos Therapeutics Major Business
2.13.3 Argos Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
2.13.4 Argos Therapeutics mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Argos Therapeutics Recent Developments/Updates
2.14 Moderna Therapeutics
2.14.1 Moderna Therapeutics Details
2.14.2 Moderna Therapeutics Major Business
2.14.3 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
2.14.4 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Moderna Therapeutics Recent Developments/Updates
2.15 NEB
2.15.1 NEB Details
2.15.2 NEB Major Business
2.15.3 NEB mRNA Vaccines and mRNA Drugs Product and Services
2.15.4 NEB mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 NEB Recent Developments/Updates
2.16 Ethris
2.16.1 Ethris Details
2.16.2 Ethris Major Business
2.16.3 Ethris mRNA Vaccines and mRNA Drugs Product and Services
2.16.4 Ethris mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Ethris Recent Developments/Updates
2.17 Aldevron
2.17.1 Aldevron Details
2.17.2 Aldevron Major Business
2.17.3 Aldevron mRNA Vaccines and mRNA Drugs Product and Services
2.17.4 Aldevron mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Aldevron Recent Developments/Updates
2.18 Promega
2.18.1 Promega Details
2.18.2 Promega Major Business
2.18.3 Promega mRNA Vaccines and mRNA Drugs Product and Services
2.18.4 Promega mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Promega Recent Developments/Updates
2.19 Translate Bio
2.19.1 Translate Bio Details
2.19.2 Translate Bio Major Business
2.19.3 Translate Bio mRNA Vaccines and mRNA Drugs Product and Services
2.19.4 Translate Bio mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Translate Bio Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MRNA VACCINES AND MRNA DRUGS BY MANUFACTURER
3.1 Global mRNA Vaccines and mRNA Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global mRNA Vaccines and mRNA Drugs Revenue by Manufacturer (2018-2023)
3.3 Global mRNA Vaccines and mRNA Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of mRNA Vaccines and mRNA Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 mRNA Vaccines and mRNA Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 mRNA Vaccines and mRNA Drugs Manufacturer Market Share in 2022
3.5 mRNA Vaccines and mRNA Drugs Market: Overall Company Footprint Analysis
3.5.1 mRNA Vaccines and mRNA Drugs Market: Region Footprint
3.5.2 mRNA Vaccines and mRNA Drugs Market: Company Product Type Footprint
3.5.3 mRNA Vaccines and mRNA Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global mRNA Vaccines and mRNA Drugs Market Size by Region
4.1.1 Global mRNA Vaccines and mRNA Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global mRNA Vaccines and mRNA Drugs Consumption Value by Region (2018-2029)
4.1.3 Global mRNA Vaccines and mRNA Drugs Average Price by Region (2018-2029)
4.2 North America mRNA Vaccines and mRNA Drugs Consumption Value (2018-2029)
4.3 Europe mRNA Vaccines and mRNA Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific mRNA Vaccines and mRNA Drugs Consumption Value (2018-2029)
4.5 South America mRNA Vaccines and mRNA Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa mRNA Vaccines and mRNA Drugs Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2029)
5.2 Global mRNA Vaccines and mRNA Drugs Consumption Value by Type (2018-2029)
5.3 Global mRNA Vaccines and mRNA Drugs Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2029)
6.2 Global mRNA Vaccines and mRNA Drugs Consumption Value by Application (2018-2029)
6.3 Global mRNA Vaccines and mRNA Drugs Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2029)
7.2 North America mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2029)
7.3 North America mRNA Vaccines and mRNA Drugs Market Size by Country
7.3.1 North America mRNA Vaccines and mRNA Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America mRNA Vaccines and mRNA Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2029)
8.2 Europe mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2029)
8.3 Europe mRNA Vaccines and mRNA Drugs Market Size by Country
8.3.1 Europe mRNA Vaccines and mRNA Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe mRNA Vaccines and mRNA Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific mRNA Vaccines and mRNA Drugs Market Size by Region
9.3.1 Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific mRNA Vaccines and mRNA Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2029)
10.2 South America mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2029)
10.3 South America mRNA Vaccines and mRNA Drugs Market Size by Country
10.3.1 South America mRNA Vaccines and mRNA Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America mRNA Vaccines and mRNA Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa mRNA Vaccines and mRNA Drugs Market Size by Country
11.3.1 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa mRNA Vaccines and mRNA Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 mRNA Vaccines and mRNA Drugs Market Drivers
12.2 mRNA Vaccines and mRNA Drugs Market Restraints
12.3 mRNA Vaccines and mRNA Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of mRNA Vaccines and mRNA Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of mRNA Vaccines and mRNA Drugs
13.3 mRNA Vaccines and mRNA Drugs Production Process
13.4 mRNA Vaccines and mRNA Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 mRNA Vaccines and mRNA Drugs Typical Distributors
14.3 mRNA Vaccines and mRNA Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of mRNA Vaccines and mRNA Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global mRNA Vaccines and mRNA Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Vaccine
1.3.3 API
1.4 Market Analysis by Application
1.4.1 Overview: Global mRNA Vaccines and mRNA Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Infectious Disease
1.4.3 Cancer
1.5 Global mRNA Vaccines and mRNA Drugs Market Size & Forecast
1.5.1 Global mRNA Vaccines and mRNA Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global mRNA Vaccines and mRNA Drugs Sales Quantity (2018-2029)
1.5.3 Global mRNA Vaccines and mRNA Drugs Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business
2.1.3 Thermo Fisher mRNA Vaccines and mRNA Drugs Product and Services
2.1.4 Thermo Fisher mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Thermo Fisher Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck mRNA Vaccines and mRNA Drugs Product and Services
2.2.4 Merck mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck Recent Developments/Updates
2.3 Qiagen N.V.
2.3.1 Qiagen N.V. Details
2.3.2 Qiagen N.V. Major Business
2.3.3 Qiagen N.V. mRNA Vaccines and mRNA Drugs Product and Services
2.3.4 Qiagen N.V. mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Qiagen N.V. Recent Developments/Updates
2.4 CureVac
2.4.1 CureVac Details
2.4.2 CureVac Major Business
2.4.3 CureVac mRNA Vaccines and mRNA Drugs Product and Services
2.4.4 CureVac mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 CureVac Recent Developments/Updates
2.5 In-Cell-Art
2.5.1 In-Cell-Art Details
2.5.2 In-Cell-Art Major Business
2.5.3 In-Cell-Art mRNA Vaccines and mRNA Drugs Product and Services
2.5.4 In-Cell-Art mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 In-Cell-Art Recent Developments/Updates
2.6 eTheRNA
2.6.1 eTheRNA Details
2.6.2 eTheRNA Major Business
2.6.3 eTheRNA mRNA Vaccines and mRNA Drugs Product and Services
2.6.4 eTheRNA mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 eTheRNA Recent Developments/Updates
2.7 Takara Bio Inc.
2.7.1 Takara Bio Inc. Details
2.7.2 Takara Bio Inc. Major Business
2.7.3 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Product and Services
2.7.4 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Takara Bio Inc. Recent Developments/Updates
2.8 Sangamo Therapeutics
2.8.1 Sangamo Therapeutics Details
2.8.2 Sangamo Therapeutics Major Business
2.8.3 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
2.8.4 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sangamo Therapeutics Recent Developments/Updates
2.9 Roche CustomBiotech
2.9.1 Roche CustomBiotech Details
2.9.2 Roche CustomBiotech Major Business
2.9.3 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Product and Services
2.9.4 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Roche CustomBiotech Recent Developments/Updates
2.10 BioNTech
2.10.1 BioNTech Details
2.10.2 BioNTech Major Business
2.10.3 BioNTech mRNA Vaccines and mRNA Drugs Product and Services
2.10.4 BioNTech mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 BioNTech Recent Developments/Updates
2.11 Tiba Biotechnology
2.11.1 Tiba Biotechnology Details
2.11.2 Tiba Biotechnology Major Business
2.11.3 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Product and Services
2.11.4 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Tiba Biotechnology Recent Developments/Updates
2.12 TriLink Bio Technologies
2.12.1 TriLink Bio Technologies Details
2.12.2 TriLink Bio Technologies Major Business
2.12.3 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Product and Services
2.12.4 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 TriLink Bio Technologies Recent Developments/Updates
2.13 Argos Therapeutics
2.13.1 Argos Therapeutics Details
2.13.2 Argos Therapeutics Major Business
2.13.3 Argos Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
2.13.4 Argos Therapeutics mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Argos Therapeutics Recent Developments/Updates
2.14 Moderna Therapeutics
2.14.1 Moderna Therapeutics Details
2.14.2 Moderna Therapeutics Major Business
2.14.3 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
2.14.4 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Moderna Therapeutics Recent Developments/Updates
2.15 NEB
2.15.1 NEB Details
2.15.2 NEB Major Business
2.15.3 NEB mRNA Vaccines and mRNA Drugs Product and Services
2.15.4 NEB mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 NEB Recent Developments/Updates
2.16 Ethris
2.16.1 Ethris Details
2.16.2 Ethris Major Business
2.16.3 Ethris mRNA Vaccines and mRNA Drugs Product and Services
2.16.4 Ethris mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Ethris Recent Developments/Updates
2.17 Aldevron
2.17.1 Aldevron Details
2.17.2 Aldevron Major Business
2.17.3 Aldevron mRNA Vaccines and mRNA Drugs Product and Services
2.17.4 Aldevron mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Aldevron Recent Developments/Updates
2.18 Promega
2.18.1 Promega Details
2.18.2 Promega Major Business
2.18.3 Promega mRNA Vaccines and mRNA Drugs Product and Services
2.18.4 Promega mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Promega Recent Developments/Updates
2.19 Translate Bio
2.19.1 Translate Bio Details
2.19.2 Translate Bio Major Business
2.19.3 Translate Bio mRNA Vaccines and mRNA Drugs Product and Services
2.19.4 Translate Bio mRNA Vaccines and mRNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Translate Bio Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MRNA VACCINES AND MRNA DRUGS BY MANUFACTURER
3.1 Global mRNA Vaccines and mRNA Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global mRNA Vaccines and mRNA Drugs Revenue by Manufacturer (2018-2023)
3.3 Global mRNA Vaccines and mRNA Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of mRNA Vaccines and mRNA Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 mRNA Vaccines and mRNA Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 mRNA Vaccines and mRNA Drugs Manufacturer Market Share in 2022
3.5 mRNA Vaccines and mRNA Drugs Market: Overall Company Footprint Analysis
3.5.1 mRNA Vaccines and mRNA Drugs Market: Region Footprint
3.5.2 mRNA Vaccines and mRNA Drugs Market: Company Product Type Footprint
3.5.3 mRNA Vaccines and mRNA Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global mRNA Vaccines and mRNA Drugs Market Size by Region
4.1.1 Global mRNA Vaccines and mRNA Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global mRNA Vaccines and mRNA Drugs Consumption Value by Region (2018-2029)
4.1.3 Global mRNA Vaccines and mRNA Drugs Average Price by Region (2018-2029)
4.2 North America mRNA Vaccines and mRNA Drugs Consumption Value (2018-2029)
4.3 Europe mRNA Vaccines and mRNA Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific mRNA Vaccines and mRNA Drugs Consumption Value (2018-2029)
4.5 South America mRNA Vaccines and mRNA Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa mRNA Vaccines and mRNA Drugs Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2029)
5.2 Global mRNA Vaccines and mRNA Drugs Consumption Value by Type (2018-2029)
5.3 Global mRNA Vaccines and mRNA Drugs Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2029)
6.2 Global mRNA Vaccines and mRNA Drugs Consumption Value by Application (2018-2029)
6.3 Global mRNA Vaccines and mRNA Drugs Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2029)
7.2 North America mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2029)
7.3 North America mRNA Vaccines and mRNA Drugs Market Size by Country
7.3.1 North America mRNA Vaccines and mRNA Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America mRNA Vaccines and mRNA Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2029)
8.2 Europe mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2029)
8.3 Europe mRNA Vaccines and mRNA Drugs Market Size by Country
8.3.1 Europe mRNA Vaccines and mRNA Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe mRNA Vaccines and mRNA Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific mRNA Vaccines and mRNA Drugs Market Size by Region
9.3.1 Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific mRNA Vaccines and mRNA Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2029)
10.2 South America mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2029)
10.3 South America mRNA Vaccines and mRNA Drugs Market Size by Country
10.3.1 South America mRNA Vaccines and mRNA Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America mRNA Vaccines and mRNA Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa mRNA Vaccines and mRNA Drugs Market Size by Country
11.3.1 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa mRNA Vaccines and mRNA Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 mRNA Vaccines and mRNA Drugs Market Drivers
12.2 mRNA Vaccines and mRNA Drugs Market Restraints
12.3 mRNA Vaccines and mRNA Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of mRNA Vaccines and mRNA Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of mRNA Vaccines and mRNA Drugs
13.3 mRNA Vaccines and mRNA Drugs Production Process
13.4 mRNA Vaccines and mRNA Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 mRNA Vaccines and mRNA Drugs Typical Distributors
14.3 mRNA Vaccines and mRNA Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global mRNA Vaccines and mRNA Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global mRNA Vaccines and mRNA Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 4. Thermo Fisher Major Business
Table 5. Thermo Fisher mRNA Vaccines and mRNA Drugs Product and Services
Table 6. Thermo Fisher mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Thermo Fisher Recent Developments/Updates
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Major Business
Table 10. Merck mRNA Vaccines and mRNA Drugs Product and Services
Table 11. Merck mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Merck Recent Developments/Updates
Table 13. Qiagen N.V. Basic Information, Manufacturing Base and Competitors
Table 14. Qiagen N.V. Major Business
Table 15. Qiagen N.V. mRNA Vaccines and mRNA Drugs Product and Services
Table 16. Qiagen N.V. mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Qiagen N.V. Recent Developments/Updates
Table 18. CureVac Basic Information, Manufacturing Base and Competitors
Table 19. CureVac Major Business
Table 20. CureVac mRNA Vaccines and mRNA Drugs Product and Services
Table 21. CureVac mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. CureVac Recent Developments/Updates
Table 23. In-Cell-Art Basic Information, Manufacturing Base and Competitors
Table 24. In-Cell-Art Major Business
Table 25. In-Cell-Art mRNA Vaccines and mRNA Drugs Product and Services
Table 26. In-Cell-Art mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. In-Cell-Art Recent Developments/Updates
Table 28. eTheRNA Basic Information, Manufacturing Base and Competitors
Table 29. eTheRNA Major Business
Table 30. eTheRNA mRNA Vaccines and mRNA Drugs Product and Services
Table 31. eTheRNA mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. eTheRNA Recent Developments/Updates
Table 33. Takara Bio Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Takara Bio Inc. Major Business
Table 35. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Product and Services
Table 36. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Takara Bio Inc. Recent Developments/Updates
Table 38. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 39. Sangamo Therapeutics Major Business
Table 40. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
Table 41. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sangamo Therapeutics Recent Developments/Updates
Table 43. Roche CustomBiotech Basic Information, Manufacturing Base and Competitors
Table 44. Roche CustomBiotech Major Business
Table 45. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Product and Services
Table 46. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Roche CustomBiotech Recent Developments/Updates
Table 48. BioNTech Basic Information, Manufacturing Base and Competitors
Table 49. BioNTech Major Business
Table 50. BioNTech mRNA Vaccines and mRNA Drugs Product and Services
Table 51. BioNTech mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. BioNTech Recent Developments/Updates
Table 53. Tiba Biotechnology Basic Information, Manufacturing Base and Competitors
Table 54. Tiba Biotechnology Major Business
Table 55. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Product and Services
Table 56. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Tiba Biotechnology Recent Developments/Updates
Table 58. TriLink Bio Technologies Basic Information, Manufacturing Base and Competitors
Table 59. TriLink Bio Technologies Major Business
Table 60. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Product and Services
Table 61. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. TriLink Bio Technologies Recent Developments/Updates
Table 63. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table 64. Argos Therapeutics Major Business
Table 65. Argos Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
Table 66. Argos Therapeutics mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Argos Therapeutics Recent Developments/Updates
Table 68. Moderna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 69. Moderna Therapeutics Major Business
Table 70. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
Table 71. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Moderna Therapeutics Recent Developments/Updates
Table 73. NEB Basic Information, Manufacturing Base and Competitors
Table 74. NEB Major Business
Table 75. NEB mRNA Vaccines and mRNA Drugs Product and Services
Table 76. NEB mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. NEB Recent Developments/Updates
Table 78. Ethris Basic Information, Manufacturing Base and Competitors
Table 79. Ethris Major Business
Table 80. Ethris mRNA Vaccines and mRNA Drugs Product and Services
Table 81. Ethris mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Ethris Recent Developments/Updates
Table 83. Aldevron Basic Information, Manufacturing Base and Competitors
Table 84. Aldevron Major Business
Table 85. Aldevron mRNA Vaccines and mRNA Drugs Product and Services
Table 86. Aldevron mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Aldevron Recent Developments/Updates
Table 88. Promega Basic Information, Manufacturing Base and Competitors
Table 89. Promega Major Business
Table 90. Promega mRNA Vaccines and mRNA Drugs Product and Services
Table 91. Promega mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Promega Recent Developments/Updates
Table 93. Translate Bio Basic Information, Manufacturing Base and Competitors
Table 94. Translate Bio Major Business
Table 95. Translate Bio mRNA Vaccines and mRNA Drugs Product and Services
Table 96. Translate Bio mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Translate Bio Recent Developments/Updates
Table 98. Global mRNA Vaccines and mRNA Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 99. Global mRNA Vaccines and mRNA Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 100. Global mRNA Vaccines and mRNA Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 101. Market Position of Manufacturers in mRNA Vaccines and mRNA Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 102. Head Office and mRNA Vaccines and mRNA Drugs Production Site of Key Manufacturer
Table 103. mRNA Vaccines and mRNA Drugs Market: Company Product Type Footprint
Table 104. mRNA Vaccines and mRNA Drugs Market: Company Product Application Footprint
Table 105. mRNA Vaccines and mRNA Drugs New Market Entrants and Barriers to Market Entry
Table 106. mRNA Vaccines and mRNA Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global mRNA Vaccines and mRNA Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 108. Global mRNA Vaccines and mRNA Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 109. Global mRNA Vaccines and mRNA Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 110. Global mRNA Vaccines and mRNA Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 111. Global mRNA Vaccines and mRNA Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 112. Global mRNA Vaccines and mRNA Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 113. Global mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Global mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Global mRNA Vaccines and mRNA Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Global mRNA Vaccines and mRNA Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Global mRNA Vaccines and mRNA Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 118. Global mRNA Vaccines and mRNA Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 119. Global mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Global mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Global mRNA Vaccines and mRNA Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 122. Global mRNA Vaccines and mRNA Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 123. Global mRNA Vaccines and mRNA Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 124. Global mRNA Vaccines and mRNA Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 125. North America mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 126. North America mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 127. North America mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 128. North America mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 129. North America mRNA Vaccines and mRNA Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 130. North America mRNA Vaccines and mRNA Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 131. North America mRNA Vaccines and mRNA Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 132. North America mRNA Vaccines and mRNA Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Europe mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 134. Europe mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 135. Europe mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 136. Europe mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 137. Europe mRNA Vaccines and mRNA Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 138. Europe mRNA Vaccines and mRNA Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 139. Europe mRNA Vaccines and mRNA Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 140. Europe mRNA Vaccines and mRNA Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 141. Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 142. Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 143. Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 144. Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 145. Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 146. Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 147. Asia-Pacific mRNA Vaccines and mRNA Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 148. Asia-Pacific mRNA Vaccines and mRNA Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 149. South America mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 150. South America mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 151. South America mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 152. South America mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 153. South America mRNA Vaccines and mRNA Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 154. South America mRNA Vaccines and mRNA Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 155. South America mRNA Vaccines and mRNA Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 156. South America mRNA Vaccines and mRNA Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 157. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 158. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 159. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 160. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 161. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 162. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 163. Middle East & Africa mRNA Vaccines and mRNA Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 164. Middle East & Africa mRNA Vaccines and mRNA Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 165. mRNA Vaccines and mRNA Drugs Raw Material
Table 166. Key Manufacturers of mRNA Vaccines and mRNA Drugs Raw Materials
Table 167. mRNA Vaccines and mRNA Drugs Typical Distributors
Table 168. mRNA Vaccines and mRNA Drugs Typical Customers
Table 1. Global mRNA Vaccines and mRNA Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global mRNA Vaccines and mRNA Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 4. Thermo Fisher Major Business
Table 5. Thermo Fisher mRNA Vaccines and mRNA Drugs Product and Services
Table 6. Thermo Fisher mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Thermo Fisher Recent Developments/Updates
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Major Business
Table 10. Merck mRNA Vaccines and mRNA Drugs Product and Services
Table 11. Merck mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Merck Recent Developments/Updates
Table 13. Qiagen N.V. Basic Information, Manufacturing Base and Competitors
Table 14. Qiagen N.V. Major Business
Table 15. Qiagen N.V. mRNA Vaccines and mRNA Drugs Product and Services
Table 16. Qiagen N.V. mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Qiagen N.V. Recent Developments/Updates
Table 18. CureVac Basic Information, Manufacturing Base and Competitors
Table 19. CureVac Major Business
Table 20. CureVac mRNA Vaccines and mRNA Drugs Product and Services
Table 21. CureVac mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. CureVac Recent Developments/Updates
Table 23. In-Cell-Art Basic Information, Manufacturing Base and Competitors
Table 24. In-Cell-Art Major Business
Table 25. In-Cell-Art mRNA Vaccines and mRNA Drugs Product and Services
Table 26. In-Cell-Art mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. In-Cell-Art Recent Developments/Updates
Table 28. eTheRNA Basic Information, Manufacturing Base and Competitors
Table 29. eTheRNA Major Business
Table 30. eTheRNA mRNA Vaccines and mRNA Drugs Product and Services
Table 31. eTheRNA mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. eTheRNA Recent Developments/Updates
Table 33. Takara Bio Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Takara Bio Inc. Major Business
Table 35. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Product and Services
Table 36. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Takara Bio Inc. Recent Developments/Updates
Table 38. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 39. Sangamo Therapeutics Major Business
Table 40. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
Table 41. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sangamo Therapeutics Recent Developments/Updates
Table 43. Roche CustomBiotech Basic Information, Manufacturing Base and Competitors
Table 44. Roche CustomBiotech Major Business
Table 45. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Product and Services
Table 46. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Roche CustomBiotech Recent Developments/Updates
Table 48. BioNTech Basic Information, Manufacturing Base and Competitors
Table 49. BioNTech Major Business
Table 50. BioNTech mRNA Vaccines and mRNA Drugs Product and Services
Table 51. BioNTech mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. BioNTech Recent Developments/Updates
Table 53. Tiba Biotechnology Basic Information, Manufacturing Base and Competitors
Table 54. Tiba Biotechnology Major Business
Table 55. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Product and Services
Table 56. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Tiba Biotechnology Recent Developments/Updates
Table 58. TriLink Bio Technologies Basic Information, Manufacturing Base and Competitors
Table 59. TriLink Bio Technologies Major Business
Table 60. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Product and Services
Table 61. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. TriLink Bio Technologies Recent Developments/Updates
Table 63. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table 64. Argos Therapeutics Major Business
Table 65. Argos Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
Table 66. Argos Therapeutics mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Argos Therapeutics Recent Developments/Updates
Table 68. Moderna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 69. Moderna Therapeutics Major Business
Table 70. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
Table 71. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Moderna Therapeutics Recent Developments/Updates
Table 73. NEB Basic Information, Manufacturing Base and Competitors
Table 74. NEB Major Business
Table 75. NEB mRNA Vaccines and mRNA Drugs Product and Services
Table 76. NEB mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. NEB Recent Developments/Updates
Table 78. Ethris Basic Information, Manufacturing Base and Competitors
Table 79. Ethris Major Business
Table 80. Ethris mRNA Vaccines and mRNA Drugs Product and Services
Table 81. Ethris mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Ethris Recent Developments/Updates
Table 83. Aldevron Basic Information, Manufacturing Base and Competitors
Table 84. Aldevron Major Business
Table 85. Aldevron mRNA Vaccines and mRNA Drugs Product and Services
Table 86. Aldevron mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Aldevron Recent Developments/Updates
Table 88. Promega Basic Information, Manufacturing Base and Competitors
Table 89. Promega Major Business
Table 90. Promega mRNA Vaccines and mRNA Drugs Product and Services
Table 91. Promega mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Promega Recent Developments/Updates
Table 93. Translate Bio Basic Information, Manufacturing Base and Competitors
Table 94. Translate Bio Major Business
Table 95. Translate Bio mRNA Vaccines and mRNA Drugs Product and Services
Table 96. Translate Bio mRNA Vaccines and mRNA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Translate Bio Recent Developments/Updates
Table 98. Global mRNA Vaccines and mRNA Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 99. Global mRNA Vaccines and mRNA Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 100. Global mRNA Vaccines and mRNA Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 101. Market Position of Manufacturers in mRNA Vaccines and mRNA Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 102. Head Office and mRNA Vaccines and mRNA Drugs Production Site of Key Manufacturer
Table 103. mRNA Vaccines and mRNA Drugs Market: Company Product Type Footprint
Table 104. mRNA Vaccines and mRNA Drugs Market: Company Product Application Footprint
Table 105. mRNA Vaccines and mRNA Drugs New Market Entrants and Barriers to Market Entry
Table 106. mRNA Vaccines and mRNA Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global mRNA Vaccines and mRNA Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 108. Global mRNA Vaccines and mRNA Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 109. Global mRNA Vaccines and mRNA Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 110. Global mRNA Vaccines and mRNA Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 111. Global mRNA Vaccines and mRNA Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 112. Global mRNA Vaccines and mRNA Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 113. Global mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Global mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Global mRNA Vaccines and mRNA Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Global mRNA Vaccines and mRNA Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Global mRNA Vaccines and mRNA Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 118. Global mRNA Vaccines and mRNA Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 119. Global mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Global mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Global mRNA Vaccines and mRNA Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 122. Global mRNA Vaccines and mRNA Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 123. Global mRNA Vaccines and mRNA Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 124. Global mRNA Vaccines and mRNA Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 125. North America mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 126. North America mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 127. North America mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 128. North America mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 129. North America mRNA Vaccines and mRNA Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 130. North America mRNA Vaccines and mRNA Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 131. North America mRNA Vaccines and mRNA Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 132. North America mRNA Vaccines and mRNA Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Europe mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 134. Europe mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 135. Europe mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 136. Europe mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 137. Europe mRNA Vaccines and mRNA Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 138. Europe mRNA Vaccines and mRNA Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 139. Europe mRNA Vaccines and mRNA Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 140. Europe mRNA Vaccines and mRNA Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 141. Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 142. Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 143. Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 144. Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 145. Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 146. Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 147. Asia-Pacific mRNA Vaccines and mRNA Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 148. Asia-Pacific mRNA Vaccines and mRNA Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 149. South America mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 150. South America mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 151. South America mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 152. South America mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 153. South America mRNA Vaccines and mRNA Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 154. South America mRNA Vaccines and mRNA Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 155. South America mRNA Vaccines and mRNA Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 156. South America mRNA Vaccines and mRNA Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 157. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 158. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 159. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 160. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 161. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 162. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 163. Middle East & Africa mRNA Vaccines and mRNA Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 164. Middle East & Africa mRNA Vaccines and mRNA Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 165. mRNA Vaccines and mRNA Drugs Raw Material
Table 166. Key Manufacturers of mRNA Vaccines and mRNA Drugs Raw Materials
Table 167. mRNA Vaccines and mRNA Drugs Typical Distributors
Table 168. mRNA Vaccines and mRNA Drugs Typical Customers
LIST OF FIGURES
Figure 1. mRNA Vaccines and mRNA Drugs Picture
Figure 2. Global mRNA Vaccines and mRNA Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Type in 2022
Figure 4. Vaccine Examples
Figure 5. API Examples
Figure 6. Global mRNA Vaccines and mRNA Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Application in 2022
Figure 8. Infectious Disease Examples
Figure 9. Cancer Examples
Figure 10. Global mRNA Vaccines and mRNA Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global mRNA Vaccines and mRNA Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global mRNA Vaccines and mRNA Drugs Sales Quantity (2018-2029) & (K Units)
Figure 13. Global mRNA Vaccines and mRNA Drugs Average Price (2018-2029) & (US$/Unit)
Figure 14. Global mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of mRNA Vaccines and mRNA Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 mRNA Vaccines and mRNA Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 mRNA Vaccines and mRNA Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Region (2018-2029)
Figure 21. North America mRNA Vaccines and mRNA Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe mRNA Vaccines and mRNA Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific mRNA Vaccines and mRNA Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. South America mRNA Vaccines and mRNA Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa mRNA Vaccines and mRNA Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. Global mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Type (2018-2029)
Figure 28. Global mRNA Vaccines and mRNA Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Application (2018-2029)
Figure 31. Global mRNA Vaccines and mRNA Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Country (2018-2029)
Figure 36. United States mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Region (2018-2029)
Figure 52. China mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. mRNA Vaccines and mRNA Drugs Market Drivers
Figure 73. mRNA Vaccines and mRNA Drugs Market Restraints
Figure 74. mRNA Vaccines and mRNA Drugs Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of mRNA Vaccines and mRNA Drugs in 2022
Figure 77. Manufacturing Process Analysis of mRNA Vaccines and mRNA Drugs
Figure 78. mRNA Vaccines and mRNA Drugs Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. mRNA Vaccines and mRNA Drugs Picture
Figure 2. Global mRNA Vaccines and mRNA Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Type in 2022
Figure 4. Vaccine Examples
Figure 5. API Examples
Figure 6. Global mRNA Vaccines and mRNA Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Application in 2022
Figure 8. Infectious Disease Examples
Figure 9. Cancer Examples
Figure 10. Global mRNA Vaccines and mRNA Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global mRNA Vaccines and mRNA Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global mRNA Vaccines and mRNA Drugs Sales Quantity (2018-2029) & (K Units)
Figure 13. Global mRNA Vaccines and mRNA Drugs Average Price (2018-2029) & (US$/Unit)
Figure 14. Global mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of mRNA Vaccines and mRNA Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 mRNA Vaccines and mRNA Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 mRNA Vaccines and mRNA Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Region (2018-2029)
Figure 21. North America mRNA Vaccines and mRNA Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe mRNA Vaccines and mRNA Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific mRNA Vaccines and mRNA Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. South America mRNA Vaccines and mRNA Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa mRNA Vaccines and mRNA Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. Global mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Type (2018-2029)
Figure 28. Global mRNA Vaccines and mRNA Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Application (2018-2029)
Figure 31. Global mRNA Vaccines and mRNA Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Country (2018-2029)
Figure 36. United States mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Region (2018-2029)
Figure 52. China mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa mRNA Vaccines and mRNA Drugs Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa mRNA Vaccines and mRNA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. mRNA Vaccines and mRNA Drugs Market Drivers
Figure 73. mRNA Vaccines and mRNA Drugs Market Restraints
Figure 74. mRNA Vaccines and mRNA Drugs Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of mRNA Vaccines and mRNA Drugs in 2022
Figure 77. Manufacturing Process Analysis of mRNA Vaccines and mRNA Drugs
Figure 78. mRNA Vaccines and mRNA Drugs Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
